Invention Grant
- Patent Title: Methods of treating colitis involving IL-13 and NK-T cells
- Patent Title (中): 治疗涉及IL-13和NK-T细胞的结肠炎的方法
-
Application No.: US12709029Application Date: 2010-02-19
-
Publication No.: US08173123B2Publication Date: 2012-05-08
- Inventor: Warren Strober , Ivan J. Fuss , Frank Heller , Richard Blumberg
- Applicant: Warren Strober , Ivan J. Fuss , Frank Heller , Richard Blumberg
- Applicant Address: US DC Washington US MA Boston
- Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,Brigham & Women's Hospital
- Current Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services,Brigham & Women's Hospital
- Current Assignee Address: US DC Washington US MA Boston
- Agency: Edwards Wildman Palmer LLP
- Agent Peter F. Corless; Andrew W. Shyjan, Esq.
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates IL-13 activity (FIG. 3). The invention also provides a method of treating or preventing the inflammatory response of colitis in a subject comprising administering to the subject an effective amount of a substance that modulates NK-T cell activity. The invention also provides for the screening of substances that treat or prevent the inflammatory response of colitis.
Public/Granted literature
- US20100143339A1 METHODS OF TREATING AND PREVENTING COLITIS INVOLVING IL-13 AND NK-T CELLS Public/Granted day:2010-06-10
Information query
